Search

Your search keyword '"Park, Cheol Young"' showing total 911 results

Search Constraints

Start Over You searched for: Author "Park, Cheol Young" Remove constraint Author: "Park, Cheol Young"
911 results on '"Park, Cheol Young"'

Search Results

9. A Study of Machine Learning Models in Predicting the Intention of Adolescents to Smoke Cigarettes

10. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

11. Predictive Situation Awareness for Ebola Virus Disease using a Collective Intelligence Multi-Model Integration Platform: Bayes Cloud

12. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: a double-blind, randomized, comparator-active study: ENHANCE-D study

14. Reference Model of Multi-Entity Bayesian Networks for Predictive Situation Awareness

15. MEBN-RM: A Mapping between Multi-Entity Bayesian Network and Relational Model

16. Human-aided Multi-Entity Bayesian Networks Learning from Relational Data

17. Gaussian Mixture Reduction for Time-Constrained Approximate Inference in Hybrid Bayesian Networks

22. Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study.

23. Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.

24. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

39. Toward maximum energy density enabled by anode‐free lithium metal batteries: Recent progress and perspective.

41. Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study

42. Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

50. Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label Trial

Catalog

Books, media, physical & digital resources